Jean-Pierre Morello, Ph.D. - Publications

2001 Université de Montréal, Montréal, Canada 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Ndong C, Pradhan A, Puma C, Morello JP, Hoffert C, Groblewski T, O'Donnell D, Laird JM. Role of rat sensory neuron-specific receptor (rSNSR1) in inflammatory pain: contribution of TRPV1 to SNSR signaling in the pain pathway. Pain. 143: 130-7. PMID 19307060 DOI: 10.1016/j.pain.2009.02.010  1
2006 Bernier V, Morello JP, Zarruk A, Debrand N, Salahpour A, Lonergan M, Arthus MF, Laperrière A, Brouard R, Bouvier M, Bichet DG. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. Journal of the American Society of Nephrology : Jasn. 17: 232-43. PMID 16319185 DOI: 10.1681/ASN.2005080854  1
2005 Gervais FG, Morello JP, Beaulieu C, Sawyer N, Denis D, Greig G, Malebranche AD, O'Neill GP. Identification of a potent and selective synthetic agonist at the CRTH2 receptor. Molecular Pharmacology. 67: 1834-9. PMID 15755909 DOI: 10.1124/mol.104.009068  1
2002 Petäjä-Repo UE, Hogue M, Bhalla S, Laperrière A, Morello JP, Bouvier M. Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. The Embo Journal. 21: 1628-37. PMID 11927547 DOI: 10.1093/emboj/21.7.1628  1
2001 Morello JP, Salahpour A, Petäjä-Repo UE, Laperrière A, Lonergan M, Arthus MF, Nabi IR, Bichet DG, Bouvier M. Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus. Biochemistry. 40: 6766-75. PMID 11389590 DOI: 10.1021/bi002699r  1
2001 Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annual Review of Physiology. 63: 607-30. PMID 11181969 DOI: 10.1146/annurev.physiol.63.1.607  1
2000 Morello JP, Petäjä-Repo UE, Bichet DG, Bouvier M. Pharmacological chaperones: a new twist on receptor folding. Trends in Pharmacological Sciences. 21: 466-9. PMID 11121835 DOI: 10.1016/S0165-6147(00)01575-3  1
2000 Morello JP, Salahpour A, Laperrière A, Bernier V, Arthus MF, Lonergan M, Petäjä-Repo U, Angers S, Morin D, Bichet DG, Bouvier M. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. The Journal of Clinical Investigation. 105: 887-95. PMID 10749568 DOI: 10.1172/JCI8688  1
1996 Morello JP, Bouvier M. Palmitoylation: a post-translational modification that regulates signalling from G-protein coupled receptors. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 74: 449-57. PMID 8960351 DOI: 10.1139/o96-049  1
1996 Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, Bouvier M. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. The Journal of Biological Chemistry. 271: 16384-92. PMID 8663163 DOI: 10.1074/jbc.271.27.16384  1
1995 Morello JP, Plamondon J, Meyrick B, Hoover R, O'Connor-McCourt MD. Transforming growth factor-beta receptor expression on endothelial cells: heterogeneity of type III receptor expression. Journal of Cellular Physiology. 165: 201-11. PMID 7559802 DOI: 10.1002/jcp.1041650123  1
Show low-probability matches.